INIS
aminotransferases
100%
epilepsy
100%
levels
71%
dopamine
71%
rats
57%
cocaine
57%
doses
42%
brain
42%
defects
42%
drugs
42%
design
28%
patients
28%
inactivation
28%
concentration
28%
anticonvulsants
28%
positron computed tomography
28%
nicotine
14%
neurons
14%
alcohols
14%
modulation
14%
refractories
14%
trade
14%
increasing
14%
screening
14%
proposals
14%
food
14%
therapy
14%
amphetamines
14%
budgets
14%
adults
14%
pediatrics
14%
chronic administration
14%
nuclei
14%
enzymes
14%
primates
14%
clinical trials
14%
crystallography
14%
humans
14%
safety
14%
inhibition
14%
heroin
14%
Pharmacology, Toxicology and Pharmaceutical Science
4 Aminobutyrate Aminotransferase
100%
Addiction
100%
Epilepsy
100%
4 Aminobutyric Acid
85%
Dopamine
71%
Vigabatrin
71%
Rat
57%
Drug
42%
Cocaine Dependence
42%
Visual Field Defect
42%
Seizure
28%
Methamphetamine Dependence
14%
Clinical Trial
14%
Human
14%
Heroin Dependence
14%
Acid
14%
Long Term Exposure
14%
Anticonvulsant Activity
14%
Tobacco Dependence
14%
Monotherapy
14%
Anticonvulsive Agent
14%
Cocaine
14%
Stimulant
14%
Infantile Spasm
14%
Enzyme
14%
Convulsion
14%
Clotiazepam
14%
Neuroscience
4 Aminobutyrate Aminotransferase
100%
Addiction
100%
Epilepsy
100%
Gamma-Aminobutyric Acid
85%
Vigabatrin
71%
Dopamine
57%
Cannabis
42%
Visual Field Defect
42%
Brain
42%
Seizure
28%
Cocaine Dependence
28%
Positron Emission Tomography
28%
Anticonvulsant
28%
Nucleus Accumbens
14%
Enzymes
14%
Methamphetamine Dependence
14%
Tobacco Dependence
14%
Dopamine Release
14%
Pediatrics
14%
Behavior (Neuroscience)
14%
Neuron
14%
Neurotransmitter
7%